Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer-Reference-Cited by-同舟云学术

Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer

Published:2013-01 Issue:1 Volume:2 Page:e22664
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Kandalaft Lana E.,Powell, Jr. Daniel J.,Chiang Cheryl L.,Tanyi Janos,Kim Sarah,Bosch Marnix,Montone Kathy,Mick Rosemarie,Levine Bruce L.,Torigian Drew A.,June Carl H.,Coukos George

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/onci.22664

Reference28 articles.

1. Immunotherapy for gynaecological malignancies

2. Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer

3. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

4. Mesothelin Variant 1 Is Released from Tumor Cells as a Diagnostic Marker

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach;Nature Reviews Clinical Oncology;2024-09-04

2. Delivery Systems Developed for Treatment Combinations to Improve Adoptive Cell Therapy;Advanced Materials;2024-08-20

3. Nucleic acid‐based vaccine for ovarian cancer cells; bench to bedside;Cell Biochemistry and Function;2024-03

4. Immunotherapy for Ovarian Cancer: Disappointing or Promising?;Molecular Pharmaceutics;2024-01-17

5. Effects of Injectable Solutions on the Quality of Monocyte‐Derived Dendritic Cells for Immunotherapy;Journal of Immunology Research;2024-01